Obigen Pharma

Obigen Pharma Inventory

Inventory of Obigen Pharma (7876.TWO) as of Oct 16, 2026.

Inventory

-TWD

Last updated:

Inventory of Obigen Pharma is 2026 - TWD. Inventory of Obigen Pharma was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Obigen Pharma Stock analysis

What does Obigen Pharma do? Obigen Pharma Inc, listed on the Taiwan Stock Exchange under ticker 7876.TWO with ISIN TW0007876005, is a biotechnology company headquartered in Zhubei, Taiwan. The company operates within the Health Care sector and currently employs 57 full-time staff. Obigen Pharma is engaged in the research, development, manufacturing, and commercialization of novel botulinum toxin products. Its primary product, OBI-858, is a type A botulinum toxin formulation currently in phase II clinical trials in Taiwan for the treatment of frown lines in medical aesthetics. The company has established a complete supply chain for OBI-858 within Taiwan, covering research, development, and production. It collaborates with contract research organizations (CROs) to support the advancement of clinical trials for its drug candidates. The company's initial public offering (IPO) is scheduled for November 24, 2025. Obigen Pharma maintains a corporate website at www.obigenpharma.com for further information. Obigen Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Obigen Pharma stock

On Eulerpool you can find the complete historical development of Inventory Obigen Pharma since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Obigen Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Obigen Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Obigen Pharma